We serve Chemical Name:(2R)-2-(3-nitro-4-phenylmethoxyphenyl)oxirane CAS:188730-94-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(2R)-2-(3-nitro-4-phenylmethoxyphenyl)oxirane
CAS.NO:188730-94-1
Synonyms:(2R)-2-(3-nitro-4-phenylmethoxyphenyl)oxirane
Molecular Formula:C15H13NO4
Molecular Weight:271.26800
HS Code:2910900090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:67.58000
Exact Mass:271.08400
LogP:3.76830
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (2R)-2-(3-nitro-4-phenylmethoxyphenyl)oxirane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2R)-2-(3-nitro-4-phenylmethoxyphenyl)oxirane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2R)-2-(3-nitro-4-phenylmethoxyphenyl)oxirane Use and application,(2R)-2-(3-nitro-4-phenylmethoxyphenyl)oxirane technical grade,usp/ep/jp grade.
Related News: Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world. (2R)-2-(3-nitro-4-phenylmethoxyphenyl)oxirane manufacturer Innova’s kit includes a nasal swab and a lateral flow test strip, which in less than a half-hour produces colored lines to display a positive reading, similar to a pregnancy test. However, the FDA said that false-negative and false-positive results may lead to delayed diagnoses, inappropriate treatment and the further spread of the virus. (2R)-2-(3-nitro-4-phenylmethoxyphenyl)oxirane supplier Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world. (2R)-2-(3-nitro-4-phenylmethoxyphenyl)oxirane vendor Innova’s kit includes a nasal swab and a lateral flow test strip, which in less than a half-hour produces colored lines to display a positive reading, similar to a pregnancy test. However, the FDA said that false-negative and false-positive results may lead to delayed diagnoses, inappropriate treatment and the further spread of the virus. (2R)-2-(3-nitro-4-phenylmethoxyphenyl)oxirane factory According to the 2013-2018 New Drug Review Summary report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.